The Sentry Sales Team was honored to attend the Indiana Business Journal Power Breakfast Series’ Life Sciences event this past Thursday. The team along with over 300 other Indiana biopharmaceutical and biotechnology leaders gained insights from a six-person panel of biopharma/life science industry experts. Topics discussed include the growing need for new talent within the life sciences space, funding and capital requirements for pharmaceutical startups, as well as the ever increasing regulatory hurdles facing contract research and drug development organizations throughout the state.
Indiana’s position as the 2nd largest state for U.S. life science exports ($9.9 billion in 2014) along with its strategic location in the U.S. provides Indiana companies a competitive edge and unique flexibility within the drug supply chain.
Sentry maximizes this advantage with its next door proximity to the country’s 2nd largest FedEx ground and air hubs, the Indianapolis International Airport and its Foreign Trade Zone (FTZ) status.